Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lumiradx Ltd (LMDX)

Lumiradx Ltd (LMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lumiradx Ltd PO BOX 1350 WINDWARD 3 REGATTA OFFICE PARK GRAND CAYMAN E9 KY1-1108 CYM

www.lumiradx.com P: 888-586-4721

Description:

LumiraDx Limited is a point of care diagnostics company. Its testing solutions are being deployed by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools and workplaces to screen, diagnose, and monitor wellness as well as disease. LumiraDx Limited, formerly known as CA Healthcare Acquisition Corp., is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 5,097
Enterprise Value, $K 271,647
Shares Outstanding, K 318,546
Annual Sales, $ 254,480 K
Annual Net Income, $ -447,790 K
Last Quarter Sales, $ 21,000 K
Last Quarter Net Income, $ -49,740 K
EBIT, $ -305,190 K
EBITDA, $ -271,900 K
60-Month Beta 1.73
% of Insider Shareholders 35.41%
% of Institutional Shareholders 9.59%
Float, K 205,749
% Float 64.59%
Short Volume Ratio 0.51

Growth:

1-Year Return -98.22%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 08/24/23
Latest Earnings Date 01/03/24
Earnings Per Share ttm -1.09
EPS Growth vs. Prev Qtr -14.29%
EPS Growth vs. Prev Year 72.41%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LMDX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -175.96%
Debt/Equity -1.74
Price/Sales 0.04
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.67
Interest Coverage -2.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar